126 related articles for article (PubMed ID: 9865016)
1. [Pharmacotherapeutical management of bronchial asthma].
Leont'ev SL; Mikhaĭlov VG; Nevzorova VP; Sadovnikova RV; Shabashov AF; Lugovkina TK; Leshchenko IV; Bel'tiukov EK; Lebedeva MK
Klin Med (Mosk); 1998; 76(10):39-41. PubMed ID: 9865016
[TBL] [Abstract][Full Text] [Related]
2. [Optimization of treatment of outpatients and inpatients with bronchial asthma in the Samara region].
Kondurtsev VA; Kupaev VI; Mishchenko OV; Fedoseeva LS
Ter Arkh; 2008; 80(1):20-3. PubMed ID: 18326221
[TBL] [Abstract][Full Text] [Related]
3. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
4. The impact of disease management on outcomes and cost of care: a study of low-income asthma patients.
Rossiter LF; Whitehurst-Cook MY; Small RE; Shasky C; Bovbjerg VE; Penberthy L; Okasha A; Green J; Ibrahim IA; Yang S; Lee K
Inquiry; 2000; 37(2):188-202. PubMed ID: 10985112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prevalence, cost, and outcomes of a combination of salmeterol and fluticasone therapy to common asthma treatments.
Wang SW; Liu X; Wiener DJ; Sennett C; Bowers BW; Legorreta AP
Am J Manag Care; 2001 Sep; 7(9):913-22. PubMed ID: 11570024
[TBL] [Abstract][Full Text] [Related]
6. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
7. [Quality assurance of drug therapy for patients with asthma. Health economic analysis].
Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK
Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacoeconomics of asthma].
Jahnz-Rózyk K; Targowski T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
[TBL] [Abstract][Full Text] [Related]
9. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
Cher DJ; Maclure M
Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
[No Abstract] [Full Text] [Related]
10. Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment.
Poluzzi E; Resi D; Zuccheri P; Motola D; De Ponti F; Vaccheri A; Montanaro N
Eur J Clin Pharmacol; 2002 Apr; 58(1):55-9. PubMed ID: 11956674
[TBL] [Abstract][Full Text] [Related]
11. Implementation of the national asthma management guidelines in the emergency department.
Al-Jahdali HH; Al-Omar AM; Al-Moamary MS; Al-Duhaim AS; Al-Hodeib AS; Hassan IS; Al-Rabegi AM
Saudi Med J; 2004 Sep; 25(9):1208-11. PubMed ID: 15448767
[TBL] [Abstract][Full Text] [Related]
12. Prescription cost-sharing and child asthma.
Shone LP; Szilagyi PG
Arch Pediatr Adolesc Med; 2008 Feb; 162(2):184-6. PubMed ID: 18250247
[No Abstract] [Full Text] [Related]
13. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
Thomas M; Kocevar VS; Zhang Q; Yin DD; Price D
Pediatrics; 2005 Jan; 115(1):129-34. PubMed ID: 15629992
[TBL] [Abstract][Full Text] [Related]
14. [Compliance and asthma--a delphi survey on therapy compliance by by asthma patients in ambulatory care].
Graf von der Schulenburg JM; Greiner W
Gesundheitswesen; 1998 Oct; 60(10):558-62. PubMed ID: 9844289
[TBL] [Abstract][Full Text] [Related]
15. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004
[TBL] [Abstract][Full Text] [Related]
16. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB
Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
[TBL] [Abstract][Full Text] [Related]
17. Long-term management of asthma: how to improve outcomes.
Self T; Nolan S
Am J Manag Care; 1997 Sep; 3(9):1425-38; quiz 1441-2. PubMed ID: 10178488
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma.
Brown R; Turk F; Dale P; Bousquet J
Allergy; 2007 Feb; 62(2):149-53. PubMed ID: 17298423
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.
Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB
J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888
[TBL] [Abstract][Full Text] [Related]
20. [The effect of cost evaluation in the treatment of asthma].
Sorli J
Med Arh; 1999; 53(3 Suppl 1):15-7. PubMed ID: 10546462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
